beta-D-GalpNAc-(1->4)-beta-D-GlcpNAc

Term ID

CHEBI:68448

Synonyms

2-(acetylamino)-4-O-[2-(acetylamino)-2-deoxy-beta-D-galactopyranosyl]-2-deoxy-beta-D-glucopyranose
2-acetamido-4-O-(2-acetamido-2-deoxy-beta-D-galactopyranosyl)-2-deoxy-beta-D-glucopyranose
beta-D-2-acetamido-2-deoxy-galactopyranosyl-(1->4)-beta-D-2-acetamido-2-deoxy-glucopyranose
beta-D-GaNAc-(1->4)-beta-D-GlcNAc
beta-D-glucopyranose, 2-(acetylamino)-4-O-[2-(acetylamino)-2-deoxy-beta-D-galactopyranosyl]-2-deoxy-
GalNAcb1-4GlcNAcb
GalNAcbeta1-4GlcNAcbeta

Definition

β-D-GalpNAc-(1→4)-D-GlcpNAc with β configuration at the reducing-end anomeric centre.

References

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from beta-D-GalpNAc-(1->4)-beta-D-GlcpNAc

Phenotype where environments contain beta-D-GalpNAc-(1->4)-beta-D-GlcpNAc

Phenotype modified by environments containing beta-D-GalpNAc-(1->4)-beta-D-GlcpNAc

Phenotype affecting beta-D-GalpNAc-(1->4)-beta-D-GlcpNAc

Human Disease Model